Hca Holdings Inc (HCA)
$85.31
4.54 (5.06%)
HCA Stock Quote Delayed 20 Minutes
Previous Close
$89.85
Market Cap
29.80B
PE Ratio
11.54
EPS
7.39
Volume (Avg. Vol.)
857,542
Day's Range
82.02 - 85.24
52-Week Range
58.38 - 151.97
Dividend & Yield
1.05 (1.23%)
HCA Stock Predictions, Articles, and Hca Holdings Inc News
Trade of the Day: HCA Healthcare Stock a Bullish Bet Worth Making
After the recent selloff HCA stock not only looks promising 'on the charts' but also has a structural tailwind worth respecting.
Aetna Uncertainty Is Keeping CVS Stock Way Undervalued
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
Top-Ranked Health Care Companies Delivering Steady Growth
Top-Ranked Health Care Companies Delivering Steady Growth Compare Brokers....
5 Value Stocks Hotter than Apple in 2018
It’s the unicorn of investing: value stocks that are breaking out. Find out what they are in this week’s podcast. Compare Brokers....
5 Value Stocks to Scoop Up at Post-Selloff Bargain Prices
Strong fundamentals that backed an extended market rally remain firmly in place. So it makes sense to buy value stocks at a bargain that could be valuable finds...
5 Top Stocks to Buy During This Bull and Bear Tug-of-War
While bullish investors show optimism on corporate earnings and prospects of tax cut, those with a bearish view fear that the Fed’s embarking on a quicker...
Quant Score Hurt HCA Healthcare (HCA) Rating
The current recommendation of Hold for HCA Healthcare Inc (NYSE:HCA) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking HCA has had from Portfolio Grader for 4 months.
Earnings Momentum Hurt HCA Healthcare (HCA) Rating
The current recommendation of Hold for HCA Healthcare Inc (NYSE:HCA) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. HCA has maintained this ranking for 4 months.
Anemic Earnings Growth Penalize HCA Healthcare (HCA) Rating
HCA Healthcare Inc (NYSE:HCA) is ranked as a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.
Quant Score Limit HCA Healthcare (HCA) Rating
With a $26.9 billion market value, HCA Healthcare Inc (NYSE:HCA) ranks in the top quarter of its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, in market value. From the vantage point of investment attractiveness, The current Portfolio Grader ranking for HCA puts it 52 among the 82 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 466 among the 781 companies in the sector, and number 2,982 in the nearly 5,000 company Portfolio Grader universe.
HCA Healthcare (HCA) Industry Group Rank Penalize Rating
HCA Healthcare Inc (NYSE:HCA) is a $28.1 billion in market value constituent of the Health Care Providers & Services GICS industry group where The current Portfolio Grader ranking for HCA puts it 47 among the 82 companies in this industry group, which is a below-average position. HCA is ranked in the third quartile of the sector with a ranking of 391 among the 782 companies in the sector and number 2,533 in the 5000 company Portfolio Grader company universe.
HCA Healthcare (HCA) Earnings Momentum Limit Rating
HCA Healthcare Inc (NYSE:HCA) is ranked as a Hold using Louis Navellier's investing system and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
